Breast cancer screening programs: Review of merits, demerits, and recent recommendations practiced across the world

Abstract

Breast cancer screening is defined as the evaluation of symptom free, otherwise healthy looking females of child bearing age or postmenopausal women for early detection of breast cancer. Screening mammography is the most common and widely practiced breast cancer screening modality across the world. The other modes of breast cancer screening being practiced across the world are: breast self-examination (BSE), clinical breast examination (CBE), digital breast tomosynthesis (DBT), ultrasonography (USG), magnetic resonance imaging (MRI), and identification of certain genetic oncogenes. The major merits of breast cancer screening programs are: early diagnosis, sorting out and prevention of risk factors, and timely treatment to lessen the morbidity (5 years localized stage survival rate is 99%, regional disease 84% while metastatic breast cancer 5 year survival rate is 23%); it also reduces overall 20% mortality rate. The major demerits of breast cancer screening are: overdiagnosis (19% from the perspective of a woman invited to screening), high cost, ionizing radiation (lifetime attributable risk to develop breast cancer is 3/10,000), false positive biopsy recommendation (about 8/1000), false negative results 11/10,000), and their consequences. Worldwide, most of the countries recommend biennial screening for breast cancer at 50–74 years of age. However, some countries recommend screening mammography earlier, starting at the age of 40 years until 70–74 years based on higher breast cancer incidence rate in those countries. This article provides a detailed review of merits, demerits, and recent recommendations for screening programs being practiced across the world.

Immunotherapy: A Challenge of Breast Cancer Treatment

“…As with other types of cancer, early diagnosis greatly increases the chances for successful treatment, allowing for a 20% reduction in overall mortality rates [5]. In this regard, despite reported handicaps of screening programs like high overdiagnosis rates and costs, risks that are derived from ionizing radiation, or false positive biopsy recommendations, both mammography, breast self-examinations, clinical breast examinations, digital breast tomosynthesis, ultrasonography, magnetic resonance imaging, and oncogene identification represent the main tools for early diagnosis, sorting out, and prevention of risk factors as well as timely treatment to lessen breast cancer morbidity [5].…”

Health Literacy in the Everyday Lives of Older Adults in Greece, Hungary, and the Netherlands

“…There have been a number of recent studies on HL in context [10]. These studies looked into, for instance, maternal HL [27], HL of young people in relation to type 2 diabetes [28] and alcohol use [29], barriers to breast cancer screening [30], and HL in relation to characteristics of welfare states in Europe [31]. Most of these recent studies on the role of context in HL use a quantitative approach and therefore do not consider the perspectives of people in much depth.…”

<p>⁸⁹Zr-Labeled Multifunctional Liposomes Conjugate Chitosan for PET-Trackable Triple-Negative Breast Cancer Stem Cell Targeted Therapy</p>

“…1 Due to increases in public awareness of cancer prevention, as well as improved levels of diagnosis and treatment, there have been modest improvements in breast cancer outcomes. 1,2 However, breast cancer is a highly heterogeneous disease. Triple-negative breast cancer (TNBC), which accounts for about 20% of cases, is generally more aggressive, with higher rates of recurrence and metastases, and a lack of effective therapeutic targets.…”